Background & Summary {#Sec1}
====================

With the rapid emergence of antibiotic microbial resistance (AMR) to all major classes of antibiotics and the decline in number of potential candidates for new antibiotics, there is a pressing need for the discovery of novel antibacterial compounds^[@CR1]^. *Streptomyces*, soil dwelling gram-positive bacteria, continue to be promising microorganisms for the production of clinically important secondary metabolites, including not only antibiotics, but also antiviral, antifungal, and antiparasitic agents, and antitumorals and immunosuppressant compounds^[@CR2]^. *Streptomyces* are distinguished by their complex life cycle and high G + C content (often over 70%) in their linear genomes^[@CR3],[@CR4]^. Traditionally, drug discovery from *Streptomyces* has been based on bioactivity screening followed by mass spectrometry and NMR-based molecular identification^[@CR5]^. However, recent advances in genomics-based approaches revealed that most of the secondary metabolite biosynthetic gene clusters (smBGCs) of streptomycetes are inactive under laboratory conditions, suggesting that the ability of streptomycetes to produce secondary metabolites has been under-estimated^[@CR5],[@CR6]^. Each *Streptomyces* species has the genetic potential to produce more than 30 secondary metabolites on average, which are diverse and differ between species^[@CR7],[@CR8]^. Considering *Streptomyces* is the largest genus of actinobacteria with approximately 900 species characterized so far, streptomycetes are a valuable resource for the discovery of novel secondary metabolites^[@CR9]^.

SmBGCs, especially polyketide and non-ribosomal peptide synthetase types, are often composed of extraordinarily long genes (\>5 kb) encoding multi-modular enzymes with repetitive domain structures. Therefore, accurate gene annotations based on high quality genome sequences are essential for the precise identification of smBGCs^[@CR10]^. Gene annotation with the high quality genome of *S. clavuligerus* revealed that 30% out of a total of 7,163 protein coding genes were incorrectly annotated in the previous draft genome of *S. clavuligerus* containing ambiguous and inaccurate nucleotides, indicating the importance of high quality genome sequences^[@CR11]^. In addition, high quality genome sequences are essential for multi-omics analysis, which facilitates the understanding of the complex regulation on smBGCs and rational engineering for increasing secondary metabolites production^[@CR11],[@CR12]^.

Among the 1,614 streptomycetes genomes that have been deposited in the NCBI Assembly database to date (as of 9th December 2019), only 189 and 35 assemblies were designated as complete genome level and chromosome level, respectively. More than 86% of assemblies were draft-quality genome sequences, which contain fragmented multiple contigs or ambiguous sequences^[@CR4],[@CR13]--[@CR15]^. One of the main obstacles to obtaining high quality genomic information of streptomycetes is the low fidelity of sequencing techniques when dealing with high G w C genomes and frequently repetitive sequences such as terminal inverted repeats^[@CR13]^. In addition, since streptomycetes have linear chromosome, it is difficult to confirm the completeness of the assembled chromosome.

In this study, we present the high-quality genome sequences of 30 streptomycetes, increasing the total number of reported complete *Streptomyces* genome by about 10%. The target streptomycetes were 22 *Streptomyces* type strains and eight different *Streptomyces venezuelae* strains, most of which are currently used as industrial strains for producing various bioactive compounds. We applied hybrid assembly strategy with long-read (PacBio) and short-read (Illumina) sequencing techniques to obtain complete genome sequences. PacBio sequencing provides long reads of several kb in length which allows the readthrough of regions with low complexity, enabling the assembly of repetitive regions, which are difficult to assemble by using Illumina sequencing reads, even with the high coverage data^[@CR16]^. However, Illumina sequencing provides reads with a lower error rate compared to the PacBio sequencing, and assembled contigs based on the Illumina sequencing reads are not simply a subset of the contigs from PacBio sequencing reads^[@CR13],[@CR17]^. Therefore, reconciling PacBio and Illumina sequencing methods enables one to generate more complete genomes by overcoming the shortcomings of each method. During the genome assembly using reads from PacBio (0.46\~5.18 Gbp) and Illumina (0.5\~3.0 Gbp) sequencing, we constructed 6.7 to 10.1 Mbp of streptomycetes genomes, most of which consist of single chromosomes with 72% G + C contents on average. Inaccurate sequences in the assembled genome were corrected using Illumina sequencing reads. The complete streptomycetes genomes have more than 97.4% gene space completeness and on average 7,000 protein coding genes, 20 rRNAs, and 68 tRNAs were annotated. Finally, based on the complete genome sequences and annotations, we predicted a total of 922 smBGCs. The complete genome sequences and newly determined smBGCs in this study should prove to be a fundamental resource for understanding the genetic basis of streptomycetes and for discovering novel secondary metabolites.

Methods {#Sec2}
=======

Genomic DNA (gDNA) extraction {#Sec3}
-----------------------------

Total 30 streptomycetes were purchased from Korean Collection for Type Cultures (KCTC, Korea). A stock of streptomycetes were inoculated to 50 mL of liquid culture medium with 0.16 g mL^−1^ of glass beads (3 ± 0.3 mm diameter) in 250 mL baffled flask and grown at 30 °C in a 200 rpm orbital shaker. Each streptomycetes was grown in one of four different culture medium, R5(--) medium (25 mM TES (pH 7.2), 103 g L^−1^ sucrose, 1% (w/v) glucose, 5 g L^−1^ yeast extract, 10.12 g L^−1^ MgCl~2~∙6H~2~O, 0.25 g L^−1^ K~2~SO~4~, 0.1 g L^−1^ casamino acids, 0.08 g L^−1^ ZnCl~2~, 0.4 mg L^−1^ FeCl~3~, 0.02 mg L^−1^ CuCl~2~∙2H~2~O, 0.02 mg L^−1^ MnCl~2~∙4H~2~O, 0.02 mg L^−1^ Na~2~B~4~O~7~∙10H~2~O, and 0.02 mg L^−1^ (NH~4~)~6~Mo~7~O~24~∙4H~2~O), 1 × sporulation medium (3.33 g L^−1^ glucose, 1 g L^−1^ yeast extract, 1 g L^−1^ beef extract, 2 g L^−1^ tryptose, and 0.006 g L^−1^ FeSO~4~∙7H~2~O), YEME medium (340 g L^−1^ sucrose, 10 g L^−1^ glucose, 3 g L^−1^ yeast extract, 5 g L^−1^ bacto peptone, and 3 g L^−1^ oxoid malt extract), and MYM medium (4 g L^−1^ maltose, 4 g L^−1^ yeast extract, 10 g L^−1^ malt extract). For gDNA extraction, 25 mL cultured cells were harvested at the exponential growth phase and washed twice with same volume of 10 mM EDTA, followed by the lysozyme (10 mg mL^−1^) treatment at 37 °C for 45 min. gDNA was extracted using a Wizard Genomic DNA Purification Kit (Promega, Madison, WI, USA) according to the manufacturer's instruction. Quality and quantity of extracted gDNA samples were evaluated using 1% agarose gel electrophoresis and Nanodrop (Thermo Fisher Scientific, Waltham, MA, USA), respectively.

Short-read (Illumina) genome sequencing {#Sec4}
---------------------------------------

For construction of short-read genome sequencing library, 2.5 μg of gDNA was sheared to approximately 350 bp by a Covaris instrument (Covaris Inc., Woburn, MA, USA) with the following conditions; Power 175, Duty factor 20%, C. burst 200, Time 23 s, 8 times. The library was constructed using a TruSeq DNA PCR-Free LT kit (Illumina Inc., San Diego, CA, USA) following manufacturer's instruction. Briefly, the fragmented DNA samples were cleaned and end-repaired, followed by the adaptor ligation and bead-based size selection ranging from 400 to 500 bp. Quantity of final libraries was measured using Qubit® dsDNA HS Assay Kit (Thermo Fisher Scientific) and the library size was determined using Agilent 2200 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Among the constructed sequencing libraries, 29 libraries were sequenced with the HiSeq. 2500 (Illumina Inc.) as 100 bp single-end reads and remaining one library for *S. tsukubaensis* was sequenced with the Miseq v.2 (Illumina Inc.) with 50 bp single-read recipe. Finally, 0.46 to 5.18 Gbp of raw sequence data were obtained and the read qualities were examined by creating sequencing QC reports function of CLC genomic workbench version 6.5.1 (CLC bio, Denmark) (Online-only Table [1](#Tab4){ref-type="table"} and Fig. [1a](#Fig1){ref-type="fig"}).Fig. 1Quality of the genome sequencing data. (**a**) Distribution of Illumina reads quality based on Phred score. (**b**) Read quality distribution of PacBio reads. Black line indicates total number of bases in the reads which have greater read quality than the corresponding read quality value on x-axis.

Long-read (PacBio) genome sequencing {#Sec5}
------------------------------------

A total of 5 μg gDNA was used as input for PacBio genome sequencing library preparation. The sequencing library was constructed with the PacBio SMRTbell^TM^ Template Prep Kit (Pacific Biosciences, Menlo Park, CA, USA) following manufacturer's instructions. Fragments smaller than 20 kbp were removed using the Blue Pippin Size selection system (Sage Science, Beverly, MA, USA) and the constructed libraries were validated using Agilent 2100 Bioanalyzer (Agilent Technologies). Final SMRTbell libraries were sequenced using one or two SMRT cells with P6-C4-chemistry (DNA Sequencing Reagent 4.0) on the PacBio RS II sequencing platform (Pacific Biosciences). Approximately, 0.5 to 3.0 Gbp of raw sequence data were generated (Online-only Table [1](#Tab4){ref-type="table"}).

Genome assembly {#Sec6}
---------------

Among the raw PacBio sequencing reads, only the reads with a read quality value greater than 0.75 and a length longer than 50 bp were filtered (Fig. [1b](#Fig1){ref-type="fig"}). Post filtered reads were assembled by the hierarchical genome assembly process workflow (HGAP, Version 2.3), including consensus polishing with Quiver^[@CR18]^. For each assembled contig, error correction was performed based on their estimated genome size and average coverage. Raw reads from the Illumina sequencing were quality trimmed using CLC genomic workbench version 6.5.1 (ambiguous limit 2 and quality limit 0.05) and assembled using *de novo* assembly function of CLC genomic workbench version 6.5.1 with default parameters. To expand the assembled contigs, all of assembled PacBio and Illumina contigs were aligned using MAUVE 2.4.0^[@CR19]^ and linked using GAP5 program (Staden package)^[@CR20]^.

Genome correction {#Sec7}
-----------------

Quality trimmed Illumina sequencing reads were mapped to the assembled genome using CLC genomic workbench version 6.5.1 (mismatch cost 2, insertion cost 3, deletion cost 3, length fraction 0.9, and similarity fraction 0.9). Conflicts showing more than 80% frequency for Illumina reads were corrected as Illumina sequence (Table [1](#Tab1){ref-type="table"}). In addition, percentage of mapped Illumina reads on to the assembled genome represents degree of completeness (Table [1](#Tab1){ref-type="table"} and Fig. [2b](#Fig2){ref-type="fig"}). Completeness of gene space was estimated using the BUSCO v3 (Table [2](#Tab2){ref-type="table"})^[@CR21]^.Table 1The statistics of genome assembly and correction.No.SpeciesFinal scaffolds (No.)Scaffold length before correction (bp)Mapped Illumina reads (%)Conflict positions (No.)Added bases (No.)Deleted bases (No.)Scaffold length after correction (bp)G + C contets (%)Assembly accession number1*Streptomyces clavuligerus*26,748,589 and 1,795,49671.16 and 14.037436,748,591 and 1,795,49572.5GCA_005519465.12*Streptomyces tsukubaensis*17,963,72795.13151507,963,74271.9GCA_003932715.13*Streptomyces galilaeus*17,756,17690.565134167,756,19471.4GCA_008704575.14*Streptomyces nitrosporeus*17,581,54393.505135167,581,56272.2GCA_008704555.15*Streptomyces subrutilus*17,604,70596.4128626907,604,97473.4GCA_008704535.16*Streptomyces viridosporus* T7A17,280,44790.44908907,280,53672.6GCA_008704515.17*Streptomyces kanamyceticus*110,133,52599.09376375310,133,89771.0GCA_008704495.18*Streptomyces aureofaciens*17,757,87384.8616957,757,87772.6GCA_008704475.19*Streptomyces prasinus*17,646,57689.701,0251,02157,647,59272.0GCA_008704445.110*Streptomyces fradiae*16,725,57497.635506,725,57974.7GCA_008704425.111*Streptomyces alboniger*17,962,59499.1219319317,962,78671.2GCA_008704395.112*Streptomyces coeruleorubidus*19,334,39999.671,2971,29909,335,69871.1GCA_008705135.113*Streptomyces cinereoruber*17,516,47499.7417817807,516,65272.9GCA_009299385.114*Streptomyces nodosus*17,772,56499.51262527,772,58770.9GCA_008704995.115*Streptomyces vinaceus*17,673,32992.4618018007,673,50972.3GCA_008704935.116*Streptomyces platensis*18,500,67399.75354352138,501,01271.1GCA_008704855.117*Streptomyces spectabilis*19,806,22295.3093493809,807,16072.4GCA_008704795.118*Streptomyces chartreusis*19,911,63798.4246146109,912,09871.0GCA_008704715.119*Stretpomyces rimosus*19,361,13296.22222209,361,15472.0GCA_008704655.120*Streptomyces albofaciens*24,757,761 and 4,494,33653.36 and 45.5350450134,757,978 and 4,494,61772.3GCA_008634025.121*Streptomyces filamentosus*25,742,252 and 2,129,92875.22 and 24.283,2183,22815,744,022 and 2,131,38573.6GCA_008634015.122*Streptomyces venezuelae* ATCC 1071218,223,43999.849681158,223,50572.5GCA_008639165.123*Streptomyces venezuelae* ATCC 2111317,893,62299.8517318107,893,80372.5GCA_008639045.124*Streptomyces venezuelae* ATCC 1059517,871,44995.50353437,871,48072.5GCA_008705255.125*Streptomyces venezuelae* ATCC 1506818,557,61599.7158758708,558,20271.9GCA_008642375.126*Streptomyces venezuelae* ATCC 1458318,018,46187.17292748,018,48471.3GCA_008642355.127*Streptomyces venezuelae* ATCC 1458418,941,82399.0025525508,942,07871.2GCA_008642315.128*Streptomyces venezuelae* ATCC 1458518,048,13982.346441268,048,15471.3GCA_008642335.129*Streptomyces venezuelae* ATCC 2178217,525,23590.50878707,525,32271.9GCA_008642295.130*Streptomyces venezuelae* ATCC 2101817,746,21491.61595747,746,26772.1GCA_008642275.1Fig. 2Genome assembly of 30 streptomycetes. (**a**) Strategy for genome assembly and corrections. (**b**) Profile of Illumina reads mapped on assembled genomes. Data were visualized using SignalMap (Roche NimbleGen, Inc.). Red line indicates the average Illumina read coverage of all genomic positions.Table 2Gene space completeness of completed genomes.No.SpeciesComplete and single-copyComplete and duplicatedFragmentedMissingTotalGene space completeness (%)1*Streptomyces clavuligerus*34300935297.42*Streptomyces tsukubaensis*35000235299.43*Streptomyces galilaeus*35100135299.74*Streptomyces nitrosporeus*352000352100.05*Streptomyces subrutilus*34900335299.16*Streptomyces viridosporus* T7A35100135299.77*Streptomyces kanamyceticus*352000352100.08*Streptomyces aureofaciens*35000235299.49*Streptomyces prasinus*35000235299.410*Streptomyces fradiae*35100135299.711*Streptomyces alboniger*35100135299.712*Streptomyces coeruleorubidus*35100135299.713*Streptomyces cinereoruber*35100135299.714*Streptomyces nodosus*35001135299.415*Streptomyces vinaceus*34901235299.116*Streptomyces platensis*35100135299.717*Streptomyces spectabilis*35001135299.418*Streptomyces chartreusis*35100135299.719*Stretpomyces rimosus*35100135299.720*Streptomyces albofaciens*34640235299.421*Streptomyces filamentosus*35100135299.722*Streptomyces venezuelae* ATCC 10712352000352100.023*Streptomyces venezuelae* ATCC 21113352000352100.024*Streptomyces venezuelae* ATCC 10595352000352100.025*Streptomyces venezuelae* ATCC 1506835100135299.726*Streptomyces venezuelae* ATCC 1458335100135299.727*Streptomyces venezuelae* ATCC 1458435100135299.728*Streptomyces venezuelae* ATCC 1458535100135299.729*Streptomyces venezuelae* ATCC 2178234900335299.130*Streptomyces venezuelae* ATCC 2101835000235299.4

Genome annotation and secondary metabolite biosynthetic gene cluster prediction {#Sec8}
-------------------------------------------------------------------------------

The complete genome sequences of streptomycetes were submitted to the NCBI GenBank database and annotated by the latest updated version of NCBI Prokaryotic Genome Annotation Pipeline (PGAP)^[@CR22]^. Using the GenBank formatted files of each genomes as input, secondary metabolite biosynthetic gene clusters were predicted by antiSMASH 4.0^[@CR23]^.

Data Records {#Sec9}
============

Raw reads from short-read (Illumina) and long-read (PacBio) sequencing were deposited in the NCBI Sequence Read Archive (SRA) (Online-only Table [1](#Tab4){ref-type="table"})^[@CR24],[@CR25]^. 30 complete genome sequences were deposited in GenBank via the NCBI's submission portal (Table [3](#Tab3){ref-type="table"})^[@CR26]--[@CR55]^. Detailed information on the predicted 922 smBGCs in 30 streptomycetes genomes has been deposited in FigShare^[@CR56]^.Table 3Summary of genome annotation.No.SpeciesCDS (No.)16s rRNA (No.)tRNA (No.)Genome accession numberBioProject accession number1*Streptomyces clavuligerus*6,8801866CP027858PRJNA4141362*Streptomyces tsukubaensis*6,3761866CP020700PRJNA3820163*Streptomyces galilaeus*6,7251876CP023703PRJNA4122924*Streptomyces nitrosporeus*6,3641874CP023702PRJNA4122925*Streptomyces subrutilus*6,4312168CP023701PRJNA4122926*Streptomyces viridosporus* T7A6,2111870CP023700PRJNA4122927*Streptomyces kanamyceticus*8,3841866CP023699PRJNA4122928*Streptomyces aureofaciens*6,4533371CP023698PRJNA4122929*Streptomyces prasinus*6,2631868CP023697PRJNA41229210*Streptomyces fradiae*5,4651865CP023696PRJNA41229211*Streptomyces alboniger*6,6131867CP023695PRJNA41229212*Streptomyces coeruleorubidus*8,0581867CP023694PRJNA41229213*Streptomyces cinereoruber*6,3921869CP023693PRJNA41229214*Streptomyces nodosus*6,4911868CP023747PRJNA41229215*Streptomyces vinaceus*6,6032168CP023692PRJNA41229216*Streptomyces platensis*7,0322167CP023691PRJNA41229217*Streptomyces spectabilis*8,2121865CP023690PRJNA41229218*Streptomyces chartreusis*8,3961871CP023689PRJNA41229219*Stretpomyces rimosus*7,7562168CP023688PRJNA41229220*Streptomyces albofaciens*7,5202167PDCM00000000PRJNA41229221*Streptomyces filamentosus*6,8322470PDCL00000000PRJNA41229222*Streptomyces venezuelae* ATCC 107127,3772167CP029197PRJNA45454723*Streptomyces venezuelae* ATCC 211136,9872167CP029196PRJNA45454724*Streptomyces venezuelae* ATCC 105956,9422167CP029195PRJNA45454725*Streptomyces venezuelae* ATCC 150687,7002169CP029194PRJNA45454726*Streptomyces venezuelae* ATCC 145837,1541866CP029193PRJNA45454727*Streptomyces venezuelae* ATCC 145847,8321865CP029192PRJNA45454728*Streptomyces venezuelae* ATCC 145857,0961866CP029191PRJNA45454729*Streptomyces venezuelae* ATCC 217826,6551869CP029190PRJNA45454730*Streptomyces venezuelae* ATCC 210186,7692171CP029189PRJNA454547

Technical Validation {#Sec10}
====================

*Streptomyces* have drawn considerable attention because of their ability to produce various clinically important secondary metabolites. Total 30 streptomycetes genomes were sequenced by using both PacBio and Illumina sequencing methods to elucidate their biosynthetic potential. After cleaning the reads, on average 98,380 PacBio reads with 11,725 bp length and 18,223,235 Illumina reads with 100 bp length (50 bp for *S. tsukubaensis*) were generated (Fig. [1a,b](#Fig1){ref-type="fig"} and Online-only Table [1](#Tab4){ref-type="table"}). Through the assembly of reads from two sequencing platforms using HGAP, CLC workbench, MAUVE, and GAP5 programs, single linear scaffolds ranging from 6.7 to 10.1 Mbp in length with 72% G + C contents were obtained for 27 streptomycetes, whereas two scaffolds were finally constructed for three remaining streptomycetes, *S. clavuligerus* (6.7 and 1.8 Mbp), *S. albofaciens* (4.8 and 4.5 Mbp), and *S. filamentosus* (5.7 and 2.1 Mbp) (Table [1](#Tab1){ref-type="table"}). *S. clavuligerus* has been reported to have a large linear plasmid with a length of 1.8 Mbp, so the genome was correctly assembled into a single chromosome, while the *S. albofaciens* and *S. filamentosus* genomes appear to be assembled into two divided scaffolds^[@CR11],[@CR57]^. To increase the accuracy of the assembled genome sequences, Illumina sequences showing more than 80% coverage at the conflict sites were taken as the corrected ones (Table [1](#Tab1){ref-type="table"}). Approximately, 96.32% of Illumina sequencing reads were successfully mapped to the corresponding genomes (Table [1](#Tab1){ref-type="table"} and Fig. [2b](#Fig2){ref-type="fig"}). The completeness of the genomes were assessed using the BUSCO approach with a total of 352 orthologue groups from the Actinobacteria Dataset^[@CR21]^. Results showed that 29 genomes have more than 99.1% gene space completeness and the *S. clavuligerus* genome has 97.4% gene space completeness (Table [2](#Tab2){ref-type="table"}). Following NCBI PGAP, 30 genomes were annotated with 7,000 protein coding genes, 20 rRNAs, and 68 tRNAs on average (Table [3](#Tab3){ref-type="table"}). Finally, based on the annotation, a total of 922 smBGCs were predicted in 30 streptomycetes genomes (Fig. [3](#Fig3){ref-type="fig"}). Detailed information, such as genomic positions, types, and putative products of each smBGC are publicly available in Figshare^[@CR56]^.Fig. 3Secondary metabolite biosynthetic gene clusters in 30 complete streptomycetes genomes.

Online-only Table {#Sec11}
=================

Online-only Table 1Summary of PacBio and Illumina genome sequencing data for 30 streptomycetes.No.SpeciesStrainPlatformRaw reads (No.)Mean raw reads length (bp)Clean reads (No.)Mean clean reads length (bp)SRA accession number1*Streptomyces clavuligerus*ATCC27064Illumina9,853,2051009,852,872100SRR9192366pacBio150,2926,57260,83415,473SRR92905512*Streptomyces tsukubaensis*NRRL18488Illumina9,181,843509,176,29950SRR9192343pacBio150,2928,16393,48112,715SRR92905503*Streptomyces galilaeus*ATCC14969Illumina15,603,98810015,603,366100SRR9192357pacBio150,2925,45895,6918,339SRR92905494*Streptomyces nitrosporeus*ATCC12769Illumina15,858,55110015,857,973100SRR9192358pacBio150,2925,007101,5727,222SRR92905485*Streptomyces subrutilus*ATCC27467Illumina23,157,47510023,157,337100SRR9192359pacBio150,2928,75792,56913,591SRR92905476*Streptomyces viridosporus T7A*ATCC39115Illumina24,919,39310024,918,458100SRR9192360pacBio150,2927,91092,13912,571SRR92905467*Streptomyces kanamyceticus*ATCC12853Illumina14,877,60610014,877,044100SRR9192361pacBio150,2925,04459,62712,291SRR92905458*Streptomyces aureofaciens*ATCC11989Illumina19,155,83210019,155,718100SRR9192362pacBio150,2925,89088,4629,681SRR92905449*Streptomyces prasinus*ATCC13879Illumina18,655,41810018,654,718100SRR9192388pacBio150,2925,56084,1079,288SRR929055310*Streptomyces fradiae*ATCC10745Illumina9,446,5131009,445,832100SRR9192354pacBio150,2926,84394,56810,538SRR929056111*Streptomyces alboniger*ATCC12461Illumina16,425,35610016,425,241100SRR9192355pacBio300,5843,638159,2706,351SRR929056012*Streptomyces coeruleorubidus*ATCC13740Illumina17,546,98110017,546,866100SRR9192339pacBio300,5842,836121,3776,164SRR929056313*Streptomyces cinereoruber*ATCC19740Illumina20,182,75410020,181,890100SRR9192340pacBio150,2923,31952,2799,266SRR929056214*Streptomyces nodosus*ATCC14899Illumina14,034,92710014,034,843100SRR9192341pacBio150,2928,38794,71912,692SRR929055715*Streptomyces vinaceus*ATCC27476Illumina6,612,1601006,610,219100SRR9192335pacBio150,2924,98475,9289,432SRR929055916*Streptomyces platensis*ATCC23948Illumina14,819,35710014,819,243100SRR9192336pacBio150,2924,86972,5739,619SRR929055817*Streptomyces spectabilis*ATCC27465Illumina18,717,01810018,716,280100SRR9192337pacBio300,58410,049202,96614,047SRR929055518*Streptomyces chartreusis*ATCC14922Illumina16,988,96610016,988,850100SRR9192338pacBio150,2928,81388,86914,106SRR929055419*Stretpomyces rimosus*ATCC10970Illumina25,109,75810025,108,764100SRR9192333pacBio300,5847,066164,89112,342SRR929056420*Streptomyces albofaciens*ATCC23873Illumina19,360,70310019,360,564100SRR9192364pacBio150,29211,091110,52114,419SRR929055221*Streptomyces filamentosus*ATCC23958Illumina21,181,46010021,180,615100SRR9192342pacBio150,2924,80570,6778,178SRR929055622*Streptomyces venezuelae* ATCC 10712ATCC 10712Illumina18,667,12210018,664,663100SRR9192374pacBio150,2929,10187,86015,328SRR929056523*Streptomyces venezuelae* ATCC 21113ATCC 21113Illumina21,561,53310021,559,491100SRR9192334pacBio150,29210,148104,69514,180SRR929056624*Streptomyces venezuelae* ATCC 10595ATCC 10595Illumina16,798,92310016,797,236100SRR9192369pacBio150,2927,82992,68112,197SRR929056725*Streptomyces venezuelae* ATCC 15068ATCC 15068Illumina15,310,62010015,308,905100SRR9192368pacBio150,29210,754107,41214,515SRR929056826*Streptomyces venezuelae* ATCC 14583ATCC 14583Illumina19,423,66810019,421,332100SRR9192371pacBio150,29210,888106,81314,647SRR929056927*Streptomyces venezuelae* ATCC 14584ATCC 14584Illumina15,447,78310015,446,240100SRR9192370pacBio150,2928,844100,52312,580SRR929054028*Streptomyces venezuelae* ATCC 14585ATCC 14585Illumina51,795,64410051,791,331100SRR9192373pacBio150,2928,27596,24312,388SRR929054129*Streptomyces venezuelae* ATCC 21782ATCC 21782Illumina19,569,33710019,567,069100SRR9192372pacBio150,2926,53970,65513,089SRR929054230*Streptomyces venezuelae* ATCC 21018ATCC 21018Illumina16,469,40610016,467,790100SRR9192375pacBio150,29210,754107,41214,515SRR9290543
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